Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call presents mixed signals. While there are positive aspects like the focus on AI-powered operations and a strong position to address debt maturity, the lack of full-year ARR guidance and unclear management responses on certain issues introduce uncertainties. The company's strategic focus areas and potential growth in MDR and exposure management are promising, but the ongoing churn and ARR decline concerns offset these positives. Given the market cap, the stock is likely to see a neutral reaction, with a possible slight tilt towards positive if growth strategies gain traction.
Annual Recurring Revenue (ARR) $839.9 million, approximately flat year-over-year. The business is digesting a mix shift towards the faster-growing detection and response business, which constitutes just over 50% of the ending ARR. The managed detection and response (MD&R) portion grew in the high-single digits.
Total Revenue $859.8 million for the full year 2025, growing 1.9% year-over-year. Q4 revenue was $217.4 million, growing 0.5% year-over-year. Growth was driven by sustained new deal activity and strategic investments in AI-enabled security operations.
Product Revenue $209.1 million in Q4, growing 1.4% year-over-year. Growth reflects the company's focus on core offerings and AI-driven enhancements.
Professional Services Revenue $8.2 million in Q4, compared to $9.9 million in Q4 2024. The decline reflects a shift in the operating model towards greater utilization of partners for professional service delivery.
Operating Income $135.7 million for the full year 2025, with a Q4 operating income of $30.1 million (13.9% margin). The sequential downtick in margin reflects ramped-up investments in global capacity centers, go-to-market teams, and product teams.
Free Cash Flow $130 million for the full year 2025, with Q4 free cash flow of $32.3 million. This reflects strong cash generation despite increased investments.
Customer Base Over 11,500 customers with an average ARR per customer of approximately $72,000. Growth in customer base and ARR per customer reflects the adoption of AI-enhanced services and solutions.
AI-enabled security operations: Strategic investments were made to strengthen Rapid7's position as a leader in AI-enabled security operations, enhancing security offerings with AI and machine learning capabilities.
Exposure Command platform: Encouraging growth was observed within the Exposure Command platform, which integrates AI tools, native telemetry, and open data integration for risk remediation.
MDR for Microsoft: Launched closer integrations with Microsoft, including MDR for Microsoft, providing 24/7 expert monitoring and native response across the Microsoft Defender suite.
Global expansion: Investments were made to scale operations globally, including expanding MDR coverage to manage third-party alerts and leveraging AI-powered services to target larger enterprises.
Partnership with Microsoft: Strengthened partnership with Microsoft to unify Microsoft telemetry with Rapid7's Command platform, enhancing security gap identification and resolution.
Operational efficiencies: Shifted repetitive SOC tasks to AI workflows, freeing security professionals for higher-value customer engagement and improving unit economics.
Sales and marketing alignment: Refined sales and marketing alignment to improve demand quality and conversion, with a focus on net-new growth, renewals, and cross-sell.
AI-driven transformation: Focused on integrating advanced AI models into core offerings, prioritizing innovation over legacy systems to maintain cutting-edge efficiency and performance.
Outcome-driven services: Emphasized delivering measurable business outcomes through a combination of data, AI innovation, and expert services, differentiating Rapid7 in the cybersecurity market.
AI-driven attacks: AI-driven attacks are escalating in pace and sophistication, stretching security teams thinner than ever. This creates a significant challenge for Rapid7 to keep up with the evolving threat landscape.
Regulatory requirements: Regulatory requirements are expanding and fragmenting globally, including new compliance mandates across regions like the EU, Asia Pacific, and U.S. states. This adds complexity and operational challenges for Rapid7 and its customers.
Competitive pressures: Rapid7 faces competitive pressures from other cybersecurity vendors, particularly in areas like managed detection and response (MDR) and exposure management. The company must continuously innovate to maintain its market position.
Operational efficiency: The company is transitioning repetitive tasks to AI workflows to improve efficiency, but this shift requires careful management to ensure service quality and customer satisfaction are not compromised.
Economic uncertainties: Economic uncertainties and potential budget constraints among customers could impact Rapid7's revenue growth and ARR, particularly as the company navigates a mix shift towards faster-growing detection and response business.
Portfolio focus: Rapid7 is strategically redefining its portfolio, prioritizing high-growth, future-ready product areas. This shift may create near-term headwinds in parts of the portfolio facing structural pressure.
Leadership and execution: Recent leadership changes and organizational restructuring aim to improve execution, but these initiatives are still in early stages and may take time to yield tangible results.
ARR (Annual Recurring Revenue): Expected to be approximately $830 million in Q1 2026, representing a 1% year-over-year decline. Full-year ARR guidance is not provided due to ongoing leadership changes and improvement initiatives.
Revenue: Total revenue for Q1 2026 is expected to range between $207 million and $209 million, reflecting a 1% year-over-year decline at the midpoint. Full-year 2026 revenue is projected to be between $835 million and $843 million, a 2% year-over-year decline at the midpoint.
Non-GAAP Operating Income: For Q1 2026, expected to range between $19 million and $21 million, with a non-GAAP operating margin of 9.6% at the midpoint. For the full year 2026, expected to range between $108 million and $116 million, with a non-GAAP operating margin of 13.3% at the midpoint.
Non-GAAP Earnings Per Share: For Q1 2026, expected to range between $0.29 and $0.32 per share. For the full year 2026, expected to range between $1.50 and $1.60 per share.
Free Cash Flow: Expected to range between $125 million and $135 million for the full year 2026, flat with prior-year performance at the midpoint, with a margin of approximately 15.5%.
The selected topic was not discussed during the call.
The earnings call presents mixed signals. While there are positive aspects like the focus on AI-powered operations and a strong position to address debt maturity, the lack of full-year ARR guidance and unclear management responses on certain issues introduce uncertainties. The company's strategic focus areas and potential growth in MDR and exposure management are promising, but the ongoing churn and ARR decline concerns offset these positives. Given the market cap, the stock is likely to see a neutral reaction, with a possible slight tilt towards positive if growth strategies gain traction.
The earnings call reflects a positive outlook with strong gross margins, strategic investments in AI and international markets, and a promising partnership with Microsoft. Despite conservative guidance, the company shows potential for growth, particularly in MDR and Exposure Command. The Q&A highlights management's confidence in their strategic direction, though cautious about forecasting due to deal variability. The market cap suggests moderate volatility, but the positive elements likely outweigh concerns, forecasting a positive stock price movement (2% to 8%) over the next two weeks.
The earnings call reflects mixed signals: the company shows strong product development and strategic initiatives, particularly in AI and partnerships, which are positive indicators. However, the lowered ARR guidance, despite a healthy pipeline and Q2 results, introduces uncertainty. The cautious approach to guidance reflects strategic deal cycles, but vague responses in the Q&A, especially regarding the India SOC and ARR adjustments, suggest potential execution risks. Given the market cap of $2.66 billion, the stock is likely to experience a neutral reaction, with minor fluctuations within the -2% to 2% range.
The earnings call reveals challenges in risk and exposure management, competitive pressures, and economic uncertainties. Despite exceeding revenue guidance and achieving strong operational performance, the company lowered its ARR guidance and acknowledged growth deceleration. The Q&A highlighted concerns about the upgrade cycle, competitive pressure, and macroeconomic effects. While there is some optimism about future stabilization, the lack of a share repurchase program and unclear management responses further contribute to a negative sentiment. Given the market cap, a stock price movement in the -2% to -8% range is expected.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.